Shuwen He

- Managed R&D actual spending, annual budget planning and long-term financial forecasting. - Financial lead for Eisai’s collaboration with Biogen, Purdue and Dova. - Alliance manager for Eisai Biogen collaboration in Alzheimer’s disease (aducanumab, BAN2401 and elenbecestat). Responsible for coordination of activities across Joint Development and Joint Steering Committees between Eisai and Biogen. - Managed competitive intelligence to support R&D portfolio strategy.

• Responsible for financial planning & analysis and decision support analytics including annual budget and quarterly forecast. • Supported and executed the Corporate Portfolio Review Committee’s financial and budget recommendations for new pharmaceutical products. • Managed daily competitive intelligence report that covers the news stories of Eisai and its competitors’ products, pharmaceutical industry and other relevant topics. • Managed and performed competitive research and analysis to support R&D portfolio strategy. Identify, analyze and interpret industry competitive intelligence and dynamics as well as their impact on Eisai’s neurology and oncology pipeline.

• Researched, composed and supervised daily competitive intelligence report for senior management. • Managed daily media monitoring and organized media coverage. • Developed media materials for business development activities. • Managed process for senior leadership and all-employee/town hall meetings. • Assisted in the review and approval of corporate financial disclosure documents summarizing key strategic goals and initiatives. • Provided communications support to promote the company’s Corporate Social Responsibility and Diversity programs.